by James on 4 August 2009
A new study has been come out for the upcoming migraine drug, tonabersat. The drug is a gap junction blocker, and researchers are hopeful that it will be specifically helpful for those with migraine with aura.
The new study confirmed this idea. The small but carefully done study showed a reduction of migraine attacks by about [...]
by James on 23 February 2008
Back in early 2006 I wrote about a new class of migraine drugs that was in the testing phases. It’s called a gap junction blocker, and the drug being tested is called tonabersat. It’s time for an update!
A major phase of the clinical trials have been completed for tonabersat. The results were encouraging, and reason [...]
by James on 16 January 2006
Testing is proceeding on a new migraine drug. I know, you hear that all the time – but this one is a little different. It’s a new type of drug, called a gap junction blocker. Gap junctions are important – everybody has them. They’re like little highways (or junctions) between your cells. Along those highways [...]